Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Italy launches COVID inquiry panel, opposition fears witch hunt

Published 06/07/2023, 15:35
Updated 06/07/2023, 15:46
© Reuters. FILE PHOTO: People wear face masks amid the coronavirus disease (COVID-19) pandemic in Milan, Italy, November 28, 2021. REUTERS/Flavio Lo Scalzo

By Angelo Amante

ROME (Reuters) - Italy's lower house of parliament on Thursday backed a parliamentary inquiry into the handling of the COVID-19 pandemic, with the opposition voicing fears of a witch hunt against those in charge at the time.

Italy was the first Western nation hard hit by coronavirus in early 2020, and the centre-left government of then prime minister Giuseppe Conte drew strong criticism from the right-wing opposition for its handling of the emergency.

The house -- now dominated by rightist forces supporting the administration of Prime Minister Giorgia Meloni -- approved a bill setting up the inquiry with 172 votes in favour. It will need final approval by the Senate.

"This is a political firing squad, for two people in particular. Giuseppe Conte and former health minister Roberto Speranza," Conte himself, who now heads the opposition 5-Star Movement, told parliament.

After the result was announced, the coalition lawmakers shouted in chorus "truth, truth." Most of the opposition refused to take part in the vote.

The World Health Organization has recorded more than 190,000 deaths from COVID-19 in Italy.

Italy is not the only country holding an inquiry into the pandemic management. An investigation was also ordered in Britain to look at how COVID-19 was handled and what mistakes were made.

A case against Conte and Speranza was dropped last month after prosecutors in the northern city of Bergamo - the epicentre of the Italian outbreak - had investigated the alleged initial mishandling of the crisis.

However, lawmakers felt a wide array of topics needed closer scrutiny from parliament, including why Italy had not updated a pandemic plan drawn up in 2006 and the legitimacy of the tough lockdown measures the government imposed.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Tommaso Foti, the lower house leader of Meloni's Brothers of Italy party, said the COVID issue caused "doubts and pain" among Italians.

Both Conte and Speranza said the bill was designed to avoid pulling the regional authorities into the inquiry, despite them having strong powers in managing healthcare in Italy. Right-wing parties are in charge of most regional administrations.

"The way you wrapped this up is an insult to Italians, to the suffering of families," Conte said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.